カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のマラリア処方薬市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Malaria Prescription Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7919）◆商品コード：GIR23SM7919
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：107
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のマラリア処方薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のマラリア処方薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- マラリア処方薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

マラリア処方薬市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・経口&非経口、静脈内

用途別セグメント
・病院、専門診療所、在宅医療、その他

主要な市場プレーヤー
・Zydus Healthcare、Sun Pharmaceutical Industries Ltd.、Sanofi SA、GSK Plc.、Novartis AG、Cipla、Viatris、Lupin、Advacare Pharma USA、VLP Therapeutics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、マラリア処方薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なマラリア処方薬メーカーの企業概要、2019年～2022年までのマラリア処方薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なマラリア処方薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別マラリア処方薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのマラリア処方薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのマラリア処方薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびマラリア処方薬の産業チェーンを掲載しています。
・第14、15章では、マラリア処方薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– マラリア処方薬の概要
– タイプ別分析（2018年vs2022年vs2029年）：経口&非経口、静脈内
– 用途別分析（2018年vs2022年vs2029年）：病院、専門診療所、在宅医療、その他
– 世界のマラリア処方薬市場規模・予測
– 世界のマラリア処方薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Zydus Healthcare、Sun Pharmaceutical Industries Ltd.、Sanofi SA、GSK Plc.、Novartis AG、Cipla、Viatris、Lupin、Advacare Pharma USA、VLP Therapeutics
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：経口&非経口、静脈内
・用途別分析2018年-2029年：病院、専門診療所、在宅医療、その他
・マラリア処方薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・マラリア処方薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・マラリア処方薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・マラリア処方薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・マラリア処方薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Malaria Prescription Medication
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Malaria Prescription Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral and Parenteral
1.3.3 Intravenous
1.4 Market Analysis by Application
1.4.1 Overview: Global Malaria Prescription Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Homecare
1.4.5 Others
1.5 Global Malaria Prescription Medication Market Size & Forecast
1.5.1 Global Malaria Prescription Medication Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Malaria Prescription Medication Sales Quantity (2018-2029)
1.5.3 Global Malaria Prescription Medication Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zydus Healthcare
2.1.1 Zydus Healthcare Details
2.1.2 Zydus Healthcare Major Business
2.1.3 Zydus Healthcare Malaria Prescription Medication Product and Services
2.1.4 Zydus Healthcare Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zydus Healthcare Recent Developments/Updates
2.2 Sun Pharmaceutical Industries Ltd.
2.2.1 Sun Pharmaceutical Industries Ltd. Details
2.2.2 Sun Pharmaceutical Industries Ltd. Major Business
2.2.3 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product and Services
2.2.4 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.3 Sanofi SA
2.3.1 Sanofi SA Details
2.3.2 Sanofi SA Major Business
2.3.3 Sanofi SA Malaria Prescription Medication Product and Services
2.3.4 Sanofi SA Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi SA Recent Developments/Updates
2.4 GSK Plc.
2.4.1 GSK Plc. Details
2.4.2 GSK Plc. Major Business
2.4.3 GSK Plc. Malaria Prescription Medication Product and Services
2.4.4 GSK Plc. Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Plc. Recent Developments/Updates
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Malaria Prescription Medication Product and Services
2.5.4 Novartis AG Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis AG Recent Developments/Updates
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Malaria Prescription Medication Product and Services
2.6.4 Cipla Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments/Updates
2.7 Viatris
2.7.1 Viatris Details
2.7.2 Viatris Major Business
2.7.3 Viatris Malaria Prescription Medication Product and Services
2.7.4 Viatris Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Viatris Recent Developments/Updates
2.8 Lupin
2.8.1 Lupin Details
2.8.2 Lupin Major Business
2.8.3 Lupin Malaria Prescription Medication Product and Services
2.8.4 Lupin Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lupin Recent Developments/Updates
2.9 Advacare Pharma USA
2.9.1 Advacare Pharma USA Details
2.9.2 Advacare Pharma USA Major Business
2.9.3 Advacare Pharma USA Malaria Prescription Medication Product and Services
2.9.4 Advacare Pharma USA Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Advacare Pharma USA Recent Developments/Updates
2.10 VLP Therapeutics
2.10.1 VLP Therapeutics Details
2.10.2 VLP Therapeutics Major Business
2.10.3 VLP Therapeutics Malaria Prescription Medication Product and Services
2.10.4 VLP Therapeutics Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 VLP Therapeutics Recent Developments/Updates
3 Competitive Environment: Malaria Prescription Medication by Manufacturer
3.1 Global Malaria Prescription Medication Sales Quantity by Manufacturer (2018-2023)
3.2 Global Malaria Prescription Medication Revenue by Manufacturer (2018-2023)
3.3 Global Malaria Prescription Medication Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Malaria Prescription Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Malaria Prescription Medication Manufacturer Market Share in 2022
3.4.2 Top 6 Malaria Prescription Medication Manufacturer Market Share in 2022
3.5 Malaria Prescription Medication Market: Overall Company Footprint Analysis
3.5.1 Malaria Prescription Medication Market: Region Footprint
3.5.2 Malaria Prescription Medication Market: Company Product Type Footprint
3.5.3 Malaria Prescription Medication Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Malaria Prescription Medication Market Size by Region
4.1.1 Global Malaria Prescription Medication Sales Quantity by Region (2018-2029)
4.1.2 Global Malaria Prescription Medication Consumption Value by Region (2018-2029)
4.1.3 Global Malaria Prescription Medication Average Price by Region (2018-2029)
4.2 North America Malaria Prescription Medication Consumption Value (2018-2029)
4.3 Europe Malaria Prescription Medication Consumption Value (2018-2029)
4.4 Asia-Pacific Malaria Prescription Medication Consumption Value (2018-2029)
4.5 South America Malaria Prescription Medication Consumption Value (2018-2029)
4.6 Middle East and Africa Malaria Prescription Medication Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Malaria Prescription Medication Sales Quantity by Type (2018-2029)
5.2 Global Malaria Prescription Medication Consumption Value by Type (2018-2029)
5.3 Global Malaria Prescription Medication Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Malaria Prescription Medication Sales Quantity by Application (2018-2029)
6.2 Global Malaria Prescription Medication Consumption Value by Application (2018-2029)
6.3 Global Malaria Prescription Medication Average Price by Application (2018-2029)
7 North America
7.1 North America Malaria Prescription Medication Sales Quantity by Type (2018-2029)
7.2 North America Malaria Prescription Medication Sales Quantity by Application (2018-2029)
7.3 North America Malaria Prescription Medication Market Size by Country
7.3.1 North America Malaria Prescription Medication Sales Quantity by Country (2018-2029)
7.3.2 North America Malaria Prescription Medication Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Malaria Prescription Medication Sales Quantity by Type (2018-2029)
8.2 Europe Malaria Prescription Medication Sales Quantity by Application (2018-2029)
8.3 Europe Malaria Prescription Medication Market Size by Country
8.3.1 Europe Malaria Prescription Medication Sales Quantity by Country (2018-2029)
8.3.2 Europe Malaria Prescription Medication Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Malaria Prescription Medication Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Malaria Prescription Medication Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Malaria Prescription Medication Market Size by Region
9.3.1 Asia-Pacific Malaria Prescription Medication Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Malaria Prescription Medication Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Malaria Prescription Medication Sales Quantity by Type (2018-2029)
10.2 South America Malaria Prescription Medication Sales Quantity by Application (2018-2029)
10.3 South America Malaria Prescription Medication Market Size by Country
10.3.1 South America Malaria Prescription Medication Sales Quantity by Country (2018-2029)
10.3.2 South America Malaria Prescription Medication Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Malaria Prescription Medication Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Malaria Prescription Medication Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Malaria Prescription Medication Market Size by Country
11.3.1 Middle East & Africa Malaria Prescription Medication Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Malaria Prescription Medication Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Malaria Prescription Medication Market Drivers
12.2 Malaria Prescription Medication Market Restraints
12.3 Malaria Prescription Medication Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Malaria Prescription Medication and Key Manufacturers
13.2 Manufacturing Costs Percentage of Malaria Prescription Medication
13.3 Malaria Prescription Medication Production Process
13.4 Malaria Prescription Medication Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Malaria Prescription Medication Typical Distributors
14.3 Malaria Prescription Medication Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Malaria Prescription Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Malaria Prescription Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zydus Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Zydus Healthcare Major Business
Table 5. Zydus Healthcare Malaria Prescription Medication Product and Services
Table 6. Zydus Healthcare Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zydus Healthcare Recent Developments/Updates
Table 8. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharmaceutical Industries Ltd. Major Business
Table 10. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product and Services
Table 11. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 13. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi SA Major Business
Table 15. Sanofi SA Malaria Prescription Medication Product and Services
Table 16. Sanofi SA Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi SA Recent Developments/Updates
Table 18. GSK Plc. Basic Information, Manufacturing Base and Competitors
Table 19. GSK Plc. Major Business
Table 20. GSK Plc. Malaria Prescription Medication Product and Services
Table 21. GSK Plc. Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Plc. Recent Developments/Updates
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Malaria Prescription Medication Product and Services
Table 26. Novartis AG Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis AG Recent Developments/Updates
Table 28. Cipla Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Major Business
Table 30. Cipla Malaria Prescription Medication Product and Services
Table 31. Cipla Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cipla Recent Developments/Updates
Table 33. Viatris Basic Information, Manufacturing Base and Competitors
Table 34. Viatris Major Business
Table 35. Viatris Malaria Prescription Medication Product and Services
Table 36. Viatris Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Viatris Recent Developments/Updates
Table 38. Lupin Basic Information, Manufacturing Base and Competitors
Table 39. Lupin Major Business
Table 40. Lupin Malaria Prescription Medication Product and Services
Table 41. Lupin Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lupin Recent Developments/Updates
Table 43. Advacare Pharma USA Basic Information, Manufacturing Base and Competitors
Table 44. Advacare Pharma USA Major Business
Table 45. Advacare Pharma USA Malaria Prescription Medication Product and Services
Table 46. Advacare Pharma USA Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Advacare Pharma USA Recent Developments/Updates
Table 48. VLP Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. VLP Therapeutics Major Business
Table 50. VLP Therapeutics Malaria Prescription Medication Product and Services
Table 51. VLP Therapeutics Malaria Prescription Medication Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. VLP Therapeutics Recent Developments/Updates
Table 53. Global Malaria Prescription Medication Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Malaria Prescription Medication Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Malaria Prescription Medication Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Malaria Prescription Medication, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Malaria Prescription Medication Production Site of Key Manufacturer
Table 58. Malaria Prescription Medication Market: Company Product Type Footprint
Table 59. Malaria Prescription Medication Market: Company Product Application Footprint
Table 60. Malaria Prescription Medication New Market Entrants and Barriers to Market Entry
Table 61. Malaria Prescription Medication Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Malaria Prescription Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Malaria Prescription Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Malaria Prescription Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Malaria Prescription Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Malaria Prescription Medication Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Malaria Prescription Medication Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Malaria Prescription Medication Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Malaria Prescription Medication Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Malaria Prescription Medication Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Malaria Prescription Medication Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Malaria Prescription Medication Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Malaria Prescription Medication Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Malaria Prescription Medication Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Malaria Prescription Medication Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Malaria Prescription Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Malaria Prescription Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Malaria Prescription Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Malaria Prescription Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Malaria Prescription Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Malaria Prescription Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Malaria Prescription Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Malaria Prescription Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Malaria Prescription Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Malaria Prescription Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Malaria Prescription Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Malaria Prescription Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Malaria Prescription Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Malaria Prescription Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Malaria Prescription Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Malaria Prescription Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Malaria Prescription Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Malaria Prescription Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Malaria Prescription Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Malaria Prescription Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Malaria Prescription Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Malaria Prescription Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Malaria Prescription Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Malaria Prescription Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Malaria Prescription Medication Raw Material
Table 121. Key Manufacturers of Malaria Prescription Medication Raw Materials
Table 122. Malaria Prescription Medication Typical Distributors
Table 123. Malaria Prescription Medication Typical Customers
List of Figures
Figure 1. Malaria Prescription Medication Picture
Figure 2. Global Malaria Prescription Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Malaria Prescription Medication Consumption Value Market Share by Type in 2022
Figure 4. Oral and Parenteral Examples
Figure 5. Intravenous Examples
Figure 6. Global Malaria Prescription Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Malaria Prescription Medication Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Specialty Clinics Examples
Figure 10. Homecare Examples
Figure 11. Others Examples
Figure 12. Global Malaria Prescription Medication Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Malaria Prescription Medication Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Malaria Prescription Medication Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Malaria Prescription Medication Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Malaria Prescription Medication Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Malaria Prescription Medication Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Malaria Prescription Medication by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Malaria Prescription Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Malaria Prescription Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Malaria Prescription Medication Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Malaria Prescription Medication Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Malaria Prescription Medication Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Malaria Prescription Medication Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Malaria Prescription Medication Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Malaria Prescription Medication Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Malaria Prescription Medication Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Malaria Prescription Medication Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Malaria Prescription Medication Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Malaria Prescription Medication Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Malaria Prescription Medication Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Malaria Prescription Medication Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Malaria Prescription Medication Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Malaria Prescription Medication Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Malaria Prescription Medication Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Malaria Prescription Medication Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Malaria Prescription Medication Consumption Value Market Share by Region (2018-2029)
Figure 54. China Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Malaria Prescription Medication Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Malaria Prescription Medication Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Malaria Prescription Medication Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Malaria Prescription Medication Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Malaria Prescription Medication Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Malaria Prescription Medication Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Malaria Prescription Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Malaria Prescription Medication Market Drivers
Figure 75. Malaria Prescription Medication Market Restraints
Figure 76. Malaria Prescription Medication Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Malaria Prescription Medication in 2022
Figure 79. Manufacturing Process Analysis of Malaria Prescription Medication
Figure 80. Malaria Prescription Medication Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のマラリア処方薬市場2023年：企業・地域・タイプ・用途別分析(Global Malaria Prescription Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のアレルギー性鼻炎治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の両面投薬トロリー市場2023年：企業・地域・タイプ・用途別分析
  • 世界の投薬カート市場2023年：企業・地域・タイプ・用途別分析
  • 世界の獣医用鎮痛剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界の工業用度付き安全メガネ市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆